Premium
A case of subgaleal metastasis from glioblastoma multiforme
Author(s) -
Nguyen Bella,
Samara Juliane,
Lee Andrew,
Fadia Mitali,
Ngu Charles,
Pranavan Ganes
Publication year - 2018
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.13818
Subject(s) - bella , medicine , radiation oncology , library science , family medicine , radiation therapy , physics , computer science , nuclear physics
Extracranial metastasis in glioblastoma multiforme (GBM) is rare; however, there are even fewer reports of subgaleal metastasis, in particular, in the case of no prior surgical intervention, as tumour seeding is thought to have been the main mechanism of metastasis. GBM is a highly malignant primary brain tumour. The prognosis is usually poor, with a reported median survival of 14.6 months with standard treatment. Extracranial metastases from GBM are considered rare, with the most common sites being the lungs, pleura, liver, lymph nodes and bone marrow. There have been less than 10 cases reported of subcutaneous metastasis from GBM. We present a case of subgaleal metastasis from GBM that is contralateral to the site of previous surgical resection. A 62-year-old normally well retired engineer was diagnosed with a left frontal lobe lesion (measuring 65 × 55 × 35 mm on MRI) following 2 weeks history of headaches, increasing confusion and short-term memory loss. Left frontal craniotomy was performed, histology confirmed GBM, negative for isocitrate dehydrogenase1. Post-operative magnetic resonance imaging (MRI) showed no evidence of residual tumour. Subsequently, he commenced concurrent chemoradiation treatment, but withdrew from treatment after only three fractions due to personal preference. At this point, he remained fit, playing squash and walking regularly. Eight months after the original diagnosis, he developed recurrent disease at the surgical bed. This was further resected and histology confirmed recurrent GBM. He recommenced adjuvant chemoradiation and completed 58 Gy in 29 fractions radiotherapy with concurrent temozolomide at 75 mg/m. One month later, he developed a soft subcutaneous lump on the contralateral side to the craniotomy, at the edge of the previous radiation field. MRI showed a new right frontal scalp subgaleal lesion measuring 20 × 20 × 15 mm in addition to progressing intra cranial disease. The scalp lesion was resected and histology reported a tumour composed of diffuse proliferation of pleomorphic astrocytes, with palisade necrosis and exuberant glomeruloid microvascular proliferation. The periphery of the specimen showed some lymphatic permeation. The final diagnosis was consistent with metastatic GBM. The surgical team confirmed that there was no instrumentation during both operations that could have caused seeding to the contralateral scalp. The patient further declined any subsequent treatment and was admitted to the hospice for the end of life care. He died 2 months later, 14 months since original diagnosis. His scalp lesion continued to grow in the hospice (Fig. 1).